Top Story

R. Michael Tuttle, MD, discusses definition, treatment of radioactive iodine-refractory patients

October 31, 2014

CORONADO, Calif. — In this video, R. Michael Tuttle, MD, professor of medicine at Memorial Sloan Kettering Cancer Center, addresses the question of how endocrinologists should define and treat patients with radioactive iodine-refractory disease.

According to Tuttle, several important sessions have tackled this issue, demonstrating patients with structural disease who no longer concentrate radioactive iodine and those whose tumors progress can be described as refractory. However, he notes the importance of questioning whether radioactive iodine is still effective in patients with advanced disease.

Meeting News Coverage

BRAF mutation linked to recurrence in differentiated thyroid cancer

October 31, 2014
CORONADO, Calif. — The incidence of the BRAF V600E mutation, in the absence of other somatic mutations, was significantly associated with locoregional recurrence…
figure Meeting News Coverage

Differentiated thyroid carcinoma benefitted from total/near-total thyroidectomy followed by RAI

October 31, 2014
CORONADO, Calif. — A survival benefit was found among patients with differentiated thyroid carcinoma who underwent total/near-total thyroidectomy followed by…
figure Meeting News CoverageVideo

Experience, training of surgeons key to improvement of thyroid surgery outcomes

October 31, 2014
CORONADO, Calif. — A surgical review of the year’s most important literature at the American Thyroid Association Annual Meeting focused on three ways to…
More News Headlines »
CME
figure

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
Meeting News Coverage Video
figure

R. Michael Tuttle, MD, discusses definition, treatment of radioactive iodine-refractory patients

October 31, 2014
CORONADO, Calif. — In this video, R. Michael Tuttle, MD, professor of medicine at Memorial Sloan Kettering Cancer…
More »
CME
figure

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »